Submitted by Anonymous (not verified) on 10 April 2026 - 10:20
Orphan designation: zanidatamab Treatment of oesophageal cancer, 21/11/2025 Positive
Source:
Orphan designation: zanidatamab Treatment of oesophageal cancer, 21/11/2025 Positive